GAD Clinical Trials

• Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes
  ClinicalTrials.gov Identifier: NCT00232375 - Completed
  GAD Ab Positive Clinically Type 2 Diabetic Patients
  
• Cognitive-Behavioral Therapy and Lexapro for GAD
  ClinicalTrials.gov Identifier: NCT00219349 - Recruiting
  Generalized Anxiety Disorder
  
• Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care
  ClinicalTrials.gov Identifier: NCT00308724 - Active, not recruiting
  Generalized Anxiety Disorder
  
• Comparing Cognitive Behaviour Therapy (CBT) With Metacognitive Therapy (MCT) in the Treatment of GAD
  ClinicalTrials.gov Identifier: NCT00426426 - Recruiting
  Generalized Anxiety Disorder
  
• Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).
  ClinicalTrials.gov Identifier: NCT00413010 - Recruiting
  General Anxiety Disorder
  
• A Study of Pregabalin in Subjects With Generalized Anxiety Disorder (GAD) Switching From Benzodiazepine Therapy
  ClinicalTrials.gov Identifier: NCT00368745 - Recruiting
  Generalized Anxiety Disorder
  
• Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD
  ClinicalTrials.gov Identifier: NCT00579280 - Recruiting
  Bipolar Disorder; Panic Disorder; Generalized Anxiety Disorder
  
• Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.
  ClinicalTrials.gov Identifier: NCT00314210 - Completed
  Anxiety Disorders
  
• GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD
  ClinicalTrials.gov Identifier: NCT00546624 - Completed
  Anxiety Disorder
  
• A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)
  ClinicalTrials.gov Identifier: NCT00248183 - Completed
  Anxiety Disorders
  
• Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)
  ClinicalTrials.gov Identifier: NCT00083980 - Terminated
  Anxiety Disorders